316 related articles for article (PubMed ID: 35063125)
1. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
3. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
Stüdle C; Nishihara H; Wischnewski S; Kulsvehagen L; Perriot S; Ishikawa H; Schroten H; Frank S; Deigendesch N; Du Pasquier R; Schirmer L; Pröbstel AK; Engelhardt B
Fluids Barriers CNS; 2023 Oct; 20(1):76. PubMed ID: 37875964
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis.
Martinez TE; Mayilsamy K; Mohapatra SS; Mohapatra S
Viruses; 2024 May; 16(5):. PubMed ID: 38793666
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 invasion of the central nervous: a brief review.
Siddiqui R; Mungroo MR; Khan NA
Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids.
Pellegrini L; Albecka A; Mallery DL; Kellner MJ; Paul D; Carter AP; James LC; Lancaster MA
Cell Stem Cell; 2020 Dec; 27(6):951-961.e5. PubMed ID: 33113348
[TBL] [Abstract][Full Text] [Related]
9. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells.
Benedetti F; Silvestri G; Mavian C; Weichseldorfer M; Munawwar A; Cash MN; Dulcey M; Vittor AY; Ciccozzi M; Salemi M; Latinovic OS; Zella D
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834998
[TBL] [Abstract][Full Text] [Related]
10. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
[TBL] [Abstract][Full Text] [Related]
11. In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity.
Fujimoto KJ; Hobbs DCF; Umeda M; Nagata A; Yamaguchi R; Sato Y; Sato A; Ohmatsu K; Ooi T; Yanai T; Kimura H; Murata T
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215982
[TBL] [Abstract][Full Text] [Related]
12. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics.
Malik JR; Acharya A; Avedissian SN; Byrareddy SN; Fletcher CV; Podany AT; Dyavar SR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239978
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
Front Immunol; 2021; 12():697329. PubMed ID: 34386007
[TBL] [Abstract][Full Text] [Related]
14. In vitro and clinical studies on the efficacy of α-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection.
Paolacci S; Ergoren MC; De Forni D; Manara E; Poddesu B; Cugia G; Dhuli K; Camilleri G; Tuncel G; Kaya Suer H; Sultanoglu N; Sayan M; Dundar M; Beccari T; Ceccarini MR; Gunsel IS; Dautaj A; Sanlidag T; Connelly ST; Tartaglia GM; Bertelli M
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):81-89. PubMed ID: 34890038
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
16. Role of host factors in SARS-CoV-2 entry.
Evans JP; Liu SL
J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196
[TBL] [Abstract][Full Text] [Related]
17. Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Higashi-Kuwata N; Yabe SG; Fukuda S; Nishida J; Tamura-Nakano M; Hattori SI; Okochi H; Mitsuya H
Microbiol Spectr; 2022 Dec; 10(6):e0349022. PubMed ID: 36314907
[TBL] [Abstract][Full Text] [Related]
18. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
